MedPath

To assess the action of Cephalandra Indica,mother tincture on HbA1C in type 2 Diabetes mellitus in age group 30-75 years as add on medicine.

Phase 3
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2022/01/039408
Lead Sponsor
DrAkalya KP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of pre diagnosed cases of type 2 diabetes mellitus.

2.Patients of pre diagnosed cases of type 2 diabetes mellitus with HbA1c levels 6.5 -9%.

3.patient who are willing to take treatment with regular follow up, who have signed the written informed consent.

Exclusion Criteria

1.patients with diabetic complications like diabetic nephropathy and cardiac manifestations will be excluded.

2.Gestational diabetes will be excluded from the study.

3.HbA1c levels more than 9% is excluded.

4.insulin dependant diabetes mellitus will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath